@article {Westcotte47, author = {Kristina A Westcott and Frances Wilkins and Amelia Chancellor and Alan Anderson and Simon Doe and Carlos Echevarria and Stephen J Bourke}, title = {The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis}, volume = {8}, number = {1}, pages = {e47--e49}, year = {2021}, doi = {10.7861/fhj.2020-0205}, publisher = {Future Healthcare Journal}, abstract = {People with cystic fibrosis (CF) were advised to undertake {\textquoteleft}shielding{\textquoteright} at home during the COVID-19 pandemic to reduce their risk of infection. We studied the impact shielding had on their wellbeing, mental health (GAD-7 and PHQ-9 scores) and adherence to treatment. 63 (46\%) of 137 people surveyed responded (19 anonymously; 44 gave their identity). Most (94\%) adhered to shielding advice {\textquoteleft}all the time/often{\textquoteright} but many (76\%) found this difficult with disruption of their routines, relationships and exercise habits. Treatment adherence rates were high and continued during COVID-19. Depression scores were low and remained stable. Clinically significant anxiety rates rose from 27\% pre-COVID-19 to 54\% during COVID-19 and seven patients requested a psychology consultation from this study. There is a need to monitor the wellbeing of people with CF during the ongoing COVID-19 pandemic.}, issn = {2514-6645}, URL = {https://www.rcpjournals.org/content/8/1/e47}, eprint = {https://www.rcpjournals.org/content/8/1/e47.full.pdf}, journal = {Future Healthcare Journal} }